Freedom to Operate Primer
Understanding FTO, why it matters for your portfolio, and what to do when there's a problem
There is a misconception in early-stage venture that gets repeated with remarkable confidence: "We filed a patent, so we're protected." It sounds right. It is not. First off, there’s no such thing as, “filing a patent.” You file a patent application. A patent is was is granted by the United States Patent and Trademark Office. A patent gives you the right to exclude others from making, using, selling, offering for sale, or importing your invention. It tells you nothing about whether your product infringes on what someone else owns. These are entirely separate legal questions, and confusing them is one of the more expensive mistakes a founding team — or their investors — can make.
Freedom to Operate (FTO) is one of the most underappreciated risk factors in early-stage investing precisely because it is invisible until it is not. A startup can have a clean IP portfolio, strong provisional filings, and excellent patent strategy — and still be building directly on top of a third party's protected method. The FTO question does not get asked enough at the seed stage. It gets asked a lot at Series B, during acquisition diligence, when the answer is hardest and most expensive to fix. This article is for managers who would rather find out early because not doing so would mean risking everything.
What Freedom to Operate Actually Means
Freedom to Operate is the legal ability to commercialize a product or service in a given market without infringing on the valid intellectual property rights of a third party. It is not the same as owning IP. It is not the same as having filed a patent application. It is a separate and independent question: can you actually sell this thing without someone else having a claim on it?
The founder misconception here is almost universal. "We patented our technology" does not mean "we are free to use our technology commercially." Patent rights are exclusionary — they give you the right to stop others from using, making, selling, offering for sale, or importing your invention. They do not grant you permission to use it yourself if doing so requires practicing someone else's patent. Think of it like land rights: owning a plot of land does not give you the right to cross your neighbor's property to get to it. Two separate questions, two separate analyses.
FTO analysis asks: Do any third-party patents cover what we are building, making, or selling?
Patent ownership asks: Do we own the rights to our own invention?
These are independent: A company can have strong patents and zero FTO — or no patents and full FTO.
Jurisdiction matters. FTO is market-specific; a product may be free to operate in the US but infringe patents held in the EU or Japan.
Why FTO Matters at the Venture Stage
IP disputes do not stay in the legal department. They shut down fundraising conversations, derail M&A timelines, and in the worst cases, force product pivots that set a company back by years. The pattern is well established: a startup builds a product, raises seed and Series A capital, starts gaining real traction — and then a larger incumbent with a broad patent portfolio sends a cease-and-desist letter. At that point, the options are expensive, the leverage is poor, and the timing is terrible.
Acquirers and later-stage investors conduct FTO analysis as a matter of routine. The question is not whether FTO will be examined — it is whether the answer will be known before or after you invest. A hidden FTO problem discovered at acquisition can collapse a deal entirely, reduce purchase price significantly, or introduce indemnification provisions that effectively transfer the risk back to early investors. The company that did a basic landscape search at seed and addressed a potential conflict early is in a fundamentally different negotiating position than the one that discovers a problem in an acquisition data room.
Common Scenarios Where FTO Issues Surface at the Worst Possible Time:
Acquisition diligence reveals a competitor's broad patent covering the company's core method
A strategic partner's IP team flags a conflict during integration planning
A Series B lead investor requires a formal FTO opinion as a condition of investment
A well-capitalized incumbent files suit shortly after a startup announces significant funding
How FTO Analysis Works
An FTO analysis is conducted by a qualified patent expert. The expert searches for third-party patents relevant to the company's product, methods, and markets — evaluating whether any claims read on what the company is doing, whether those claims are valid and enforceable, and whether there are design-around options if conflicts exist.
The scope of an FTO analysis covers several dimensions simultaneously: specific product features and methods being commercialized, the markets and jurisdictions where the product will be sold, and the competitive patent landscape in the relevant technology area. It is also emphatically not a one-time exercise. As a product evolves — new features, new markets, new technical approaches — the FTO picture changes. A clean opinion at seed does not guarantee a clean position at Series B if the product has materially changed.
How Fund Managers Can Push Founders in the Right Direction
Most founders have never heard the phrase "freedom to operate" before their Series A process. That is not entirely their fault — the IP ecosystem does a poor job of communicating this concept at early stages. Fund managers who understand FTO can add real value by introducing the concept early, framing it constructively, and building it into standard deal processes.
The most effective approach is to normalize FTO as a routine question rather than an alarm bell. Founders respond very differently to "have you looked at what else is out there in your space?" than to "we need to verify that you aren't infringing anyone's patents." The former is a strategic conversation. The latter sounds like an accusation. Frame FTO as competitive intelligence — understanding the landscape, knowing where the land mines are, and building a product roadmap that takes the IP environment into account.
Practical Ways to Integrate FTO into Your Investment Process
Ask the question early and informally: In initial conversations, inquire whether the founding team has done any patent landscape research. The answer tells you about their IP sophistication regardless of what they found.
Include FTO in standard diligence checklists: Not as a full legal opinion for every deal, but as a question that gets asked and answered at every stage-appropriate level.
Flag it in term sheet conditions: For seed or Series A leads in technical domains, consider including a condition that basic FTO landscape work be completed before close — or within 90 days post-close.
Encourage early engagement with an IP expert: A one-hour consultation with a patent expert to discuss the competitive landscape costs very little and can surface issues that would cost enormously more to fix later.
When Something Has Already Gone Wrong
Despite best efforts, FTO problems emerge. A founder discovers a competing patent after the investment closes. A cease-and-desist letter arrives. A larger competitor files suit. These scenarios are not automatic disasters — but they require a clear-eyed response framework and often move faster than founders expect.
The response depends on the nature and severity of the conflict. There are four primary paths, and the right one depends on the strength of the third-party patent, the importance of the contested method to the product, and the relative resources of the parties involved:
Challenge validity (Inter Partes Review): If the third-party patent appears weak — obvious prior art, overly broad claims, questionable novelty — an IPR petition at the USPTO can be a cost-effective way to challenge the patent's validity. IPR proceedings typically cost $50,000–$150,000, but can result in invalidation of the problematic patent entirely.
Design around: Can the product be modified to achieve the same technical result through a different method that does not read on the third-party claims? Design-arounds are often underexplored because founders assume any change to the architecture is a concession. In practice, a well-executed design-around can eliminate the infringement risk entirely.
License: Licensing is not a failure — it is a commercial resolution. Many IP conflicts that initially look adversarial resolve through a licensing arrangement, sometimes with a cross-license if the portfolio company has IP of value to the other party.
Fight: Full patent litigation is expensive, slow, and distracting. At the startup stage, it is rarely the first choice — but occasionally the only choice. Managers should know that IP litigation funding has emerged as a meaningful option, with third-party funders providing capital for litigation in exchange for a share of proceeds. IP insurance products also exist and are worth understanding before a dispute arises.
Trade Secrets as Part of the FTO Picture
FTO analysis focuses primarily on patents, but trade secrets deserve a mention in any comprehensive IP risk discussion — both because they represent an alternative protection strategy and because they carry their own category of risk. A trade secret is any business information that derives value from not being generally known and is subject to reasonable efforts to maintain its secrecy.
The trade secret path is not passive. Courts have been clear that "reasonable efforts to maintain secrecy" means active, documented steps: non-disclosure agreements with all parties who have access, access controls limiting who can see sensitive information, employee training and exit procedures that address confidential information, and internal policies that make clear what is confidential and what is not. A company that claims trade secret protection but has none of these measures in place will not prevail in court. The Coca-Cola formula has survived over 130 years of protection — not because the law protects it automatically, but because the company has actively maintained its secrecy with discipline.
The key trade secret risk in a venture portfolio is employee departure. When an employee who knows your core trade secret leaves — especially for a competitor — the exposure is significant. Well-drafted confidentiality provisions in employment agreements, combined with clear exit procedures and documented access controls, are the primary defenses. Managers should ensure portfolio companies have these basics in place long before the first departure of a key employee.
A Manager's FTO Checklist
Use these questions across your portfolio — at initial diligence, at each follow-on, and as portfolio companies approach significant milestones:
Has the founding team done any patent landscape search in their technology area?
Are there known incumbents with broad IP portfolios in this space?
Has an IP expert been consulted on FTO, even informally, before product launch?
Is FTO included in your standard diligence checklist at each stage?
Do portfolio companies have trade secret protection measures formally in place?
Has the FTO picture been revisited as the product has evolved?
Does your portfolio have awareness of IP litigation funding and insurance as tools?
Don't underestimate Freedom to Operate.
Freedom to Operate is the IP risk that founders do not know to worry about and investors often forget to ask about — right up until it becomes the only thing anyone can talk about. The good news is that early attention is not too costly, and the framework for managing FTO risk is straightforward: ask the question early, do stage-appropriate landscape work, engage an IP expert before product launch, and build FTO checkpoints into your standard diligence and portfolio management processes. The startups that understand their IP environment — not just what they own, but what exists around them — are the ones that arrive at acquisition conversations with clean answers. That is a competitive advantage worth cultivating.